Tech Company Financing Transactions

PMV Pharmaceuticals Funding Round

Boxer Capital, Nextech Invest and OrbiMed joined a $70 million Series D funding round for PMV Pharmaceuticals. The round was announced on 8/4/2020.

Transaction Overview

Announced On
8/4/2020
Transaction Type
Venture Equity
Amount
$70,000,000
Round
Series D
Investors

Boxer Capital

Nextech Invest

OrbiMed (Peter Thompson)

RA Capital

Viking Global Investors

Wellington Management Company

Proceeds Purpose
The proceeds will be used to advance PMV Pharma's p53 product candidates.

Company Information

Company Status
Publicly-held
Industry
Biopharmaceutical
Mailing Address
8 Clarke Dr. 3
Cranbury, NJ 08512
USA
Phone
Undisclosed
Email Address
Overview
PMV Pharmaceuticals (Nasdaq: PMVP) is developing first-in-class p53 and p53 pathway modulators for the treatment of cancer. Bringing together leaders in the field to utilize over three decades of p53 biology, PMV combines unique biological understanding with pharmaceutical development focus.
Profile
PMV Pharmaceuticals LinkedIn Company Profile
Social Media
PMV Pharmaceuticals Company Twitter Account
Company News
PMV Pharmaceuticals News
Facebook
PMV Pharmaceuticals on Facebook
YouTube
PMV Pharmaceuticals on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
David Mack
  David Mack LinkedIn Profile  David Mack Twitter Account  David Mack News  David Mack on Facebook
Chief Medical Officer
Leila Alland
  Leila Alland LinkedIn Profile  Leila Alland Twitter Account  Leila Alland News  Leila Alland on Facebook
Chief Operating Officer
Winston Kung
  Winston Kung LinkedIn Profile  Winston Kung Twitter Account  Winston Kung News  Winston Kung on Facebook
Vice President
Thomas Davis
  Thomas Davis LinkedIn Profile  Thomas Davis Twitter Account  Thomas Davis News  Thomas Davis on Facebook
Vice President
Melissa Dumble
  Melissa Dumble LinkedIn Profile  Melissa Dumble Twitter Account  Melissa Dumble News  Melissa Dumble on Facebook
Vice President
Binh Vu
  Binh Vu LinkedIn Profile  Binh Vu Twitter Account  Binh Vu News  Binh Vu on Facebook
VP - Regulatory Affairs
Deepika Jalota
  Deepika Jalota LinkedIn Profile  Deepika Jalota Twitter Account  Deepika Jalota News  Deepika Jalota on Facebook


 

 

Browse more venture capital transactions:

Prev: 8/3/2020: Delightree venture capital transaction
Next: 8/4/2020: Volante Technologies venture capital transaction

 

Share this article

 


About Database of VC Transactions

We do our best to report on every notable VC transaction. VC investment data records on this site are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary